Company Filing History:
Years Active: 1988-1991
Title: Larry A. Gatlin: Innovator in Pharmaceutical Compositions
Introduction
Larry A. Gatlin is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions containing human tissue plasminogen activator. With a total of 3 patents to his name, Gatlin's work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents, Gatlin has developed novel, stable pharmaceutically acceptable compositions that contain human tissue plasminogen activator. These compositions feature an argininium ion containing buffer as a key component. Additionally, he has disclosed associated means and methods for preparing and using such compositions in various forms. This innovation aims to enhance the stability and efficacy of therapeutic applications.
Career Highlights
Larry A. Gatlin is currently associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to explore and develop groundbreaking pharmaceutical solutions that address critical health challenges.
Collaborations
Throughout his career, Gatlin has collaborated with esteemed colleagues, including William F. Bennett and Stuart E. Builder. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in the pharmaceutical industry.
Conclusion
Larry A. Gatlin's contributions to pharmaceutical compositions demonstrate his commitment to innovation and improvement in medical treatments. His work continues to pave the way for advancements in the field, showcasing the importance of research and collaboration in driving progress.